Performing immunohistochemistry analysis in 108 esophageal cancer tissues, we discovered that advanced esophageal cancer tissues (Stage III and IV) had noticeably greater levels of PGK1 expression than that in early phase esophageal cancer (Stage I‐II) (Figure 5A). This evidence concerns the gene PGK1 and esophageal cancer.